Fangzhou Inc., a leader in AI-driven Internet healthcare solutions, and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) announced the signing of a strategic collaboration agreement in Shanghai, ahead of World Psoriasis Day. Fangzhou’s Founder, Chairman and CEO, Dr. Xie Fangmin and Li Mei, Co-CEO of Fosun Pharma’s Domestic Marketing Platform, attended the signing ceremony on behalf of the companies.
Fangzhou and Fosun Pharma plan to build an extensive partnership in AI-powered chronic disease management, initially focused on psoriasis and other autoimmune conditions. The companies will jointly pursue flagship digital health initiatives that integrate AI-assisted patient education, academic research dissemination, digital marketing, and long-term disease management, and thereby supporting the goals of the Healthy China 2030 initiative.
Psoriasis is a chronic, recurring inflammatory disorder that requires long-term, evidence-based care. Traditional disease management models face challenges such as poor adherence and limited follow-up outside hospital settings. Leveraging Fangzhou’s proprietary “XingShi” Large Language Model (“XS LLM”) and “AI+H2H (Hospital-to-Home)” ecosystem, along with Fosun Pharma’s Otezla® (Apremilast, a novel PDE4 inhibitor for the treatment of psoriasis), and strong commercial platform, the companies aim to create a comprehensive, AI-powered psoriasis management system that enables precision assessment, personalized treatment, and ongoing care support.
Dr. Xie remarked, “We are pleased to establish this strategic partnership with Fosun Pharma. This collaboration represents not only a synergy of strengths but also a new milestone in Fangzhou’s AI strategy. Together, we aim to pioneer a new model for AI-powered psoriasis management and ultimately expand this framework across a range of chronic diseases.”
Through this collaboration, Fangzhou’s AI Health Manager will offer personalised care guidance and monitoring, while its AI Medication Finder provides 24/7 medication information services. For more complex inquiries, users can connect with licensed medical consultants to receive professional, evidence-based support, ensuring safety and adherence throughout the treatment process.
